Evidence map›Paper›PMID 41783501›Full record

ArticleFrontiers in microbiology2026

Correction: Broad-spectrum inhibition of SARS-CoV-2 variants by dibutyl phthalate through allosteric disruption of Spike-ACE2 interface.

Jiafan Chen, Dekuan Guo, Xiaoxuan Guo, Lijun Zhao, Geng Li, Helu Liu, Shaobo Wang, Zizhao Lao, Meiling Zhu

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Jiafan ChenShenzhen Baoan Women's and Children's Hospital, Shenzhen, Guangdong, China.
Dekuan GuoState Key Laboratory of Traditional Chinese Medicine Syndrome, Guangzhou University of Chinese Medicine, Guangzhou, China.
Xiaoxuan GuoShenzhen Traditional Chinese Medicine Hospital, Shenzhen, Guangdong, China.
Lijun ZhaoShenzhen Clinical College of Integrated Chinese and Western Medicine, Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, China.
Geng LiState Key Laboratory of Traditional Chinese Medicine Syndrome, Guangzhou University of Chinese Medicine, Guangzhou, China.
Helu LiuShenzhen Clinical College of Integrated Chinese and Western Medicine, Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, China.
Shaobo WangGuangzhou National Laboratory, Department of Basic Research, Guangzhou International Bio-Island, Guangzhou, China.
Zizhao LaoChinese Medicine Guangdong Laboratory, Hengqin, Guangdong, China.
Meiling ZhuShenzhen Traditional Chinese Medicine Hospital, Shenzhen, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fmicb.2025.1610775.].

Indexed as

cell membrane fusiondibutyl phthalateSARS-CoV-2site-directed mutagenesisSpike-ACE2 interactionstructure optimizationviral entry inhibitor

Identifiers

PMID41783501
PMCPMC12954516

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.